Brain Mechanisms of Reducing Polysubstance Use

The proposed study will test whether neurofeedback (NF) could optimize integrative body-mind training (IBMT) practice.

Lead sponsor: Arizona State University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

YiYuan Tang

CONTACT

4807903577 yiyuan@asu.edu

Related studies

UNKNOWNPhase 4

A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

NCT01758679 · Multiple Drug Use

COMPLETEDNA

Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation

NCT01689493 · Coronary Artery Stent Thrombosis, Multiple Drug Use, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 4, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment35

Start dateSep 2023

Last updatedMay 4, 2026

Condition

Multiple Drug Use

Locations shown

YiYuan Tang

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions